Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Cash Flow Reinvestment Rate
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting CN¥3.59 Million (capex CN¥3.59 Million ) from operating cash flow of CN¥294.76 Million. Check Guizhou Bailing Group Pharmaceutical Co cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Guizhou Bailing Group Pharmaceutical Co Ltd across 15 annual periods. Explore long-term investment intensity of Guizhou Bailing Group Pharmaceutical Co to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Guizhou Bailing Group Pharmaceutical Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Guizhou Bailing Group Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market cap of Guizhou Bailing Group Pharmaceutical Co .
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥131.71 Million | CN¥748.72 Million | CN¥125.24 Million | ▼ -99.1% |
| 2024 | 20.46x | CN¥184.60 Million | CN¥9.02 Million | CN¥42.02 Million | ▲ +1892.6% |
| 2023 | 1.03x | CN¥129.16 Million | CN¥125.77 Million | CN¥104.12 Million | ▲ +245.6% |
| 2022 | 0.30x | CN¥149.20 Million | CN¥502.15 Million | CN¥68.45 Million | ▼ -83.6% |
| 2021 | 1.81x | CN¥587.80 Million | CN¥324.92 Million | CN¥425.73 Million | ▲ +318.8% |
| 2020 | 0.43x | CN¥100.12 Million | CN¥231.78 Million | CN¥90.02 Million | ▼ -65.6% |
| 2019 | 1.26x | CN¥587.02 Million | CN¥467.41 Million | CN¥121.91 Million | ▼ -55.3% |
| 2017 | 2.81x | CN¥224.68 Million | CN¥79.88 Million | CN¥144.68 Million | ▲ +321.2% |
| 2016 | 0.67x | CN¥311.62 Million | CN¥466.62 Million | CN¥159.34 Million | ▲ +22.7% |
| 2015 | 0.54x | CN¥224.99 Million | CN¥413.23 Million | CN¥121.04 Million | ▲ +123.4% |
| 2014 | 0.24x | CN¥96.49 Million | CN¥395.83 Million | CN¥96.49 Million | ▼ -61.1% |
| 2013 | 0.63x | CN¥88.74 Million | CN¥141.76 Million | CN¥88.74 Million | ▼ -93.2% |
| 2012 | 9.23x | CN¥180.16 Million | CN¥19.52 Million | CN¥180.16 Million | ▲ +865.3% |
| 2011 | 0.96x | CN¥193.07 Million | CN¥201.90 Million | CN¥193.07 Million | ▲ +446.8% |
| 2009 | 0.17x | CN¥21.91 Million | CN¥125.31 Million | CN¥21.91 Million | — |